Two Sigma Ventures

Terray Therapeutics

terraytherapeutics.com

Terray Therapeutics is a biotechnology company that revolutionizes small molecule drug discovery by integrating high-quality experimental data with advanced AI techniques. Their platform is designed to enhance the speed, cost, and success rate of drug development, boasting an experimental dataset of over two billion unique target-ligand binding measurements, which grows by 300 million each month. With a focus on immunology and partnerships with large pharma and biotech, Terray aims to address complex therapeutic challenges through a rapid design-make-test-analyze cycle that allows for the exploration of millions of molecules simultaneously. This innovative approach positions Terray as a leader in the generative AI space for drug discovery, making it an attractive investment opportunity.